{"id":"W2037186296","doi":"10.1038/sj.bjp.0703012","title":"Bradyzide, a potent non‐peptide B<sub>2</sub> bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesia","year":2000,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Bradykinin; Bradykinin receptor; Receptor; Receptor antagonist; Chemistry; Antagonist; Extravasation; Agonist; Pharmacology; Internal medicine; Endocrinology; Biology; Biochemistry; Medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005028914,0.0002824176,0.0009337646,0.0002869438,0.0001132542,0.00003736147,0.0001983916,0.0001783391,0.0004135132],"category_scores_gemma":[0.00003549492,0.0003027346,0.0002281355,0.000365992,0.0002439427,0.0006252723,0.00004034174,0.000691941,0.00000872915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001783595,"about_ca_system_score_gemma":0.0005477518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001997692,"about_ca_topic_score_gemma":0.0002115272,"domain_scores_codex":[0.9974348,0.0002201733,0.001016389,0.0003228598,0.0004634479,0.0005423272],"domain_scores_gemma":[0.9985415,0.0001394806,0.0006293689,0.0000990034,0.0003057448,0.0002848518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.006826662,0.001111873,0.05758819,0.0002277967,0.0004083902,0.004443276,0.0003455939,0.002556335,0.7542064,0.000009531749,0.00419806,0.1680778],"study_design_scores_gemma":[0.01386245,0.002383525,0.564767,0.001124879,0.0004257597,0.01469888,0.00007841676,0.004779719,0.3970587,0.00005012981,0.0003198361,0.0004506734],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971555,0.001306529,0.0001594496,0.0004486001,0.0002320297,0.0003730698,0.00002126225,0.00002758407,0.0002759528],"genre_scores_gemma":[0.9968623,0.001344106,0.0006853855,0.0003731526,0.0005331782,0.000009636053,0.000009865754,0.00005781354,0.0001245611],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5071788,"threshold_uncertainty_score":0.9999425,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01295841605836955,"score_gpt":0.2558401944795877,"score_spread":0.2428817784212181,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}